Teachers Retirement System of The State of Kentucky trimmed its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,215 shares of the medical research company’s stock after selling 1,413 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in IQVIA were worth $3,132,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. Capital Performance Advisors LLP bought a new stake in IQVIA in the third quarter valued at $27,000. Park Place Capital Corp acquired a new stake in shares of IQVIA in the 3rd quarter valued at $28,000. Itau Unibanco Holding S.A. bought a new stake in shares of IQVIA in the 2nd quarter worth about $29,000. International Assets Investment Management LLC acquired a new stake in shares of IQVIA during the 2nd quarter worth about $32,000. Finally, Avior Wealth Management LLC lifted its holdings in IQVIA by 117.6% during the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock valued at $38,000 after purchasing an additional 87 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
IQV has been the subject of several recent analyst reports. TD Cowen dropped their price objective on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a report on Friday, November 1st. The Goldman Sachs Group dropped their price target on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a report on Friday, November 1st. Morgan Stanley reduced their price objective on IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. William Blair reaffirmed an “outperform” rating on shares of IQVIA in a report on Wednesday. Finally, BTIG Research decreased their price objective on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, IQVIA currently has an average rating of “Moderate Buy” and an average target price of $256.19.
IQVIA Price Performance
Shares of IQV opened at $199.06 on Friday. The stock has a market cap of $36.13 billion, a P/E ratio of 26.12, a price-to-earnings-growth ratio of 2.07 and a beta of 1.49. IQVIA Holdings Inc. has a 1 year low of $187.62 and a 1 year high of $261.73. The stock’s 50-day moving average price is $212.24 and its two-hundred day moving average price is $224.21. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76.
About IQVIA
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Featured Articles
- Five stocks we like better than IQVIA
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the NASDAQ Stock Exchange?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.